Fidson Healthcare Plc (NGX:FIDSON)
Nigeria · Delayed Price · Currency is NGN 80.00
+1.00 (1.27%)
At close: Sep 4, 2026
Fidson Healthcare Ratios and Metrics
Market cap in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 231,600 | 114,979 | 35,572 | 40,162 | 20,655 | 12,977 | |
Market Cap Growth | 134.69% | 223.23% | -11.43% | 94.44% | 59.16% | 38.22% |
Enterprise Value | 243,012 | 146,595 | 66,959 | 53,634 | 33,477 | 22,196 |
Last Close Price | 80.00 | 49.35 | 14.57 | 15.77 | 7.82 | 4.71 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.05 | 11.63 | 8.09 | 11.13 | 4.93 | 3.49 |
Forward PE | 17.08 | 6.60 | 6.60 | 6.60 | 6.60 | 6.60 |
PS Ratio | 1.77 | 0.97 | 0.42 | 0.76 | 0.51 | 0.42 |
PB Ratio | 3.92 | 3.81 | 1.59 | 2.08 | 1.22 | 0.94 |
P/TBV Ratio | 3.93 | 3.84 | 1.60 | 2.08 | 1.22 | 0.95 |
P/FCF Ratio | 8.75 | 13.06 | - | - | - | 5.81 |
P/OCF Ratio | 5.76 | 6.84 | - | 25.95 | 5.52 | 2.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.86 | 1.23 | 0.80 | 1.01 | 0.82 | 0.72 |
EV/EBITDA Ratio | 7.81 | 4.84 | 3.26 | 5.13 | 3.68 | 3.43 |
EV/EBIT Ratio | 8.54 | 5.23 | 3.54 | 5.80 | 4.08 | 3.84 |
EV/FCF Ratio | 9.18 | 16.65 | - | - | - | 9.94 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.42 | 1.12 | 1.47 | 1.48 | 0.88 | 0.80 |
Debt / EBITDA Ratio | 0.79 | 1.11 | 1.60 | 2.72 | 1.62 | 1.67 |
Debt / FCF Ratio | 0.93 | 3.82 | - | - | - | 4.91 |
Net Debt / Equity Ratio | 0.19 | 0.96 | 1.25 | 0.92 | 0.76 | 0.66 |
Net Debt / EBITDA Ratio | 0.37 | 0.96 | 1.36 | 1.70 | 1.40 | 1.39 |
Net Debt / FCF Ratio | 0.43 | 3.29 | -6.45 | -6.13 | -4.45 | 4.04 |
Asset Turnover | 1.33 | 1.55 | 1.24 | 1.01 | 1.07 | 1.02 |
Inventory Turnover | 2.23 | 2.12 | 1.76 | 1.76 | 1.66 | 1.66 |
Quick Ratio | 0.93 | 0.38 | 0.28 | 0.51 | 0.33 | 0.38 |
Current Ratio | 1.69 | 1.18 | 1.22 | 1.18 | 1.27 | 1.59 |
Return on Equity (ROE) | 26.06% | 37.62% | 21.13% | 19.92% | 27.30% | 30.63% |
Return on Assets (ROA) | 18.11% | 22.81% | 17.47% | 11.01% | 13.49% | 11.97% |
Return on Invested Capital (ROIC) | 28.64% | 33.86% | 24.76% | 16.89% | 22.68% | 22.08% |
Return on Capital Employed (ROCE) | 41.90% | 72.20% | 55.60% | 31.70% | 32.90% | 26.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.00% | 8.60% | 12.37% | 8.98% | 20.27% | 28.67% |
FCF Yield | 11.43% | 7.66% | -12.21% | -7.22% | -13.91% | 17.22% |
Dividend Yield | 1.90% | 3.04% | 6.86% | 3.81% | 7.03% | 9.65% |
Payout Ratio | 20.29% | 23.77% | 31.30% | 35.19% | 24.91% | 13.78% |
Buyback Yield / Dilution | -20.14% | -4.58% | - | - | 0.00% | - |
Total Shareholder Return | -18.25% | -1.54% | 6.86% | 3.81% | 7.03% | 9.65% |